Clinical Trials Logo

Clinical Trial Summary

The PICoC study aims to investigate whether oral ferric maltol given postoperatively offers an improvement in patient and clinician reported outcomes compared to standard care.


Clinical Trial Description

Colorectal cancer is associated with iron deficiency anaemia in 40-60% of cases. This anaemia can lead to poorer post-operative outcomes such as higher complication rates, increased length of stay and reduced survival. There has been a recent shift towards the correction of preoperative anaemia in order to optimize perioperative outcomes. However, despite improvements in preoperative haemoglobin there exists a group of patients who develop worsening or recurrent anaemia in the post-operative period. Without intervention up to 90% of patients in the immediate postoperative period may develop anaemia. This is not unexpected given the peri-operative blood loss; poor nutritional intake in the postoperative period; and the frequent blood sampling for laboratory tests. Our data from previous trials has demonstrated that despite preoperative intravenous iron therapy 75% of patients remain anaemic at the time of their colorectal cancer operation. In addition, our unpublished data has found that around 1/3 of patients treated with preoperative iron therapy develop a recurrence of their anaemia in the first year postoperatively. Studies have identified that traditional oral ferrous iron supplementation is largely ineffective for the treatment of postoperative anaemia. However, a newer oral iron preparation - ferric maltol (Ferracru) has been found to be better tolerated and more efficacious than ferrous iron. This study aims to evaluate whether the use of iron supplementation in the form of Feraccru could lead to a more sustained or improved a response in haemoglobin if given after a colorectal cancer operation. Improving this postoperative anaemia may have important implications for clinician and patient reported outcomes. The Perioperative Iron in Colorectal Cancer (PICoC) trial will run as a feasibility study to assess the proposed design, recruitability and outcome measures. Anaemic colorectal cancer patients treated with preoperative intravenous iron will be randomised in an open label design to receive a course of Ferric maltol (intervention group) or standard care (control group) postoperatively. Secondary outcome measures will focus on a comparison of change in blood indices, quality of life, allogenic red blood transfusion rates and postoperative complications between groups. Follow up will continue until the first postoperative outpatient visit at approximately 12 weeks following discharge. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05177484
Study type Interventional
Source The Royal Wolverhampton Hospitals NHS Trust
Contact Matthew Brookes
Phone 01902307999
Email matthew.brookes@nhs.net
Status Recruiting
Phase Phase 3
Start date May 30, 2022
Completion date May 29, 2025

See also
  Status Clinical Trial Phase
Completed NCT03179358 - Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC N/A
Recruiting NCT03976960 - Clinical and Biological Database in Colon Cancer and Colic Tumors N/A
Recruiting NCT06119425 - Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands N/A
Not yet recruiting NCT04079946 - The Efficacy Of Complete Mesocolic Excision With Central Vessel Ligation Technique On Lymph Nodes And Safety Margins Compared With Conventional Surgery For Colon Cancer Treatment N/A
Completed NCT03951792 - Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
Recruiting NCT06391749 - Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Recruiting NCT03722121 - Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?
Not yet recruiting NCT05154474 - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Recruiting NCT04972994 - Laparoscopic Colectomies In Management of Colonic Cancers N/A
Recruiting NCT02542670 - Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients. N/A
Completed NCT03688906 - AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Completed NCT05225870 - Significance of Cortactin Expression in Colorectal Adenocarcinomas N/A
Completed NCT04400552 - Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients N/A
Withdrawn NCT03185416 - Early Palliative Care Integration in Interventional Cancer Care N/A
Completed NCT01533090 - Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy N/A